Switzerland Biosensors Market Size, Share & Trends Analysis Report By Technology (Thermal, Electrochemical, Piezoelectric, Optical), By Application, By End Use (Food Industry, Research Laboratories, PoC Testing), And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business days
Switzerland Biosensors Market Growth & Trends
The Switzerland biosensors market size is estimated t%li%reach USD 764.8 million by 2030, expanding at a CAGR of 9.6% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. Various applications of biosensors in medical fields, rising prevalence of diabetes, high demand for miniature diagnostic device, and rapid technological advancements are the key factors driving the growth.
Various government initiatives aimed at development of proteomics and genomics are expected t%li%drive the market for biosensors. Most of the IT companies are als%li%significantly investing in product development. Increasing investments by major IT players such as Infosys, TCS, and IBM are expected t%li%boost the Switzerland biosensors market.
The players in biosensors industry are undertaking various strategies t%li%strengthen their product portfolios and offer diverse technologically advanced and innovative products t%li%their customers. Partnerships, acquisitions, and product launches are the most prominently adopted strategies by the companies t%li%attract more customers. In addition, increasing prevalence of type I and type II diabetes in Switzerland is expected t%li%drive the market over the forecast period. According t%li%the International Diabetes Federation, in 2017, around 547,654 cases of diabetes were reported in Switzerland, which is anticipated t%li%fuel the market growth over the forecast period.
Switzerland Biosensors Market Report Highlights
Switzerland Biosensors Market Growth & Trends
The Switzerland biosensors market size is estimated t%li%reach USD 764.8 million by 2030, expanding at a CAGR of 9.6% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. Various applications of biosensors in medical fields, rising prevalence of diabetes, high demand for miniature diagnostic device, and rapid technological advancements are the key factors driving the growth.
Various government initiatives aimed at development of proteomics and genomics are expected t%li%drive the market for biosensors. Most of the IT companies are als%li%significantly investing in product development. Increasing investments by major IT players such as Infosys, TCS, and IBM are expected t%li%boost the Switzerland biosensors market.
The players in biosensors industry are undertaking various strategies t%li%strengthen their product portfolios and offer diverse technologically advanced and innovative products t%li%their customers. Partnerships, acquisitions, and product launches are the most prominently adopted strategies by the companies t%li%attract more customers. In addition, increasing prevalence of type I and type II diabetes in Switzerland is expected t%li%drive the market over the forecast period. According t%li%the International Diabetes Federation, in 2017, around 547,654 cases of diabetes were reported in Switzerland, which is anticipated t%li%fuel the market growth over the forecast period.
Switzerland Biosensors Market Report Highlights
- On the basis of technology, the electrochemical segment held the largest revenue share of over 71.5% in 2024 owing t%li%their widespread applications for quantification and analysis in biochemical and biological processes.
- Biosensors in agriculture industry is expected t%li%witness the fastest CAGR over the forecast period owing t%li%the rising demand for sensor technology in the field.
- The PoC testing segment held the largest revenue share at 48.8% in 2024. Increasing demand for portable and rapid point-of-care diagnostic devices that can be used outside conventional laboratories is one of the key drivers.
- Prominent players present in the Switzerland biosensors market are Abbott, Biosensor International Group, Ltd., Bayer AG, Lucentix SA, Xsensio, and Sensirion AG Switzerland, Innovative Sensor Technology (IST) AG.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology Segment
2.2.2. Application Segment
2.2.3. End Use Segment
2.2.4. Regional Outlook
2.3. Competitive Insights
CHAPTER 3. SWITZERLAND BIOSENSORS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of diabetes
3.2.1.2. Rising incidence of infectious diseases
3.2.1.3. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with the devices and procedures
3.2.2.2. Regulatory compliance
3.3. Switzerland Biosensors Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. SWITZERLAND BIOSENSORS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
4.1. Switzerland Biosensors Market: Technology Dashboard
4.2. Switzerland Biosensors Market: Technology Movement Analysis
4.3. Switzerland Biosensors Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
4.4. Electrochemical
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Thermal
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Optical
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Piezoelectric
4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. SWITZERLAND BIOSENSORS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Switzerland Biosensors Market: Application Dashboard
5.2. Switzerland Biosensors Market: Application Movement Analysis
5.3. Switzerland Biosensors Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Medical
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.2. Cholesterol
5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.3. Blood Glucose
5.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.4. Pregnancy Testing
5.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.5. Drug Discovery
5.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.6. Infectious Disease
5.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Food Toxicity
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Bioreactor
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.7. Agriculture
5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.8. Environment
5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. SWITZERLAND BIOSENSORS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Switzerland Biosensors Market: End Use Dashboard
6.2. Switzerland Biosensors Market: End Use Movement Analysis
6.3. Switzerland Biosensors Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Home Healthcare Diagnostics
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. PoC Testing
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Food industry
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.7. Research Laboratories
6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.8. Security and Bio-defense
6.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Abbott Laboratories
7.3.4.1. Company Overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Biosensors International Group Ltd
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Bayer AG
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Xsensio
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Lucentix SA
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Sensirion AG Switzerland
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Innovative Sensor Technology (IST) AG
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology Segment
2.2.2. Application Segment
2.2.3. End Use Segment
2.2.4. Regional Outlook
2.3. Competitive Insights
CHAPTER 3. SWITZERLAND BIOSENSORS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of diabetes
3.2.1.2. Rising incidence of infectious diseases
3.2.1.3. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with the devices and procedures
3.2.2.2. Regulatory compliance
3.3. Switzerland Biosensors Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. SWITZERLAND BIOSENSORS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
4.1. Switzerland Biosensors Market: Technology Dashboard
4.2. Switzerland Biosensors Market: Technology Movement Analysis
4.3. Switzerland Biosensors Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
4.4. Electrochemical
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Thermal
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Optical
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Piezoelectric
4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. SWITZERLAND BIOSENSORS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Switzerland Biosensors Market: Application Dashboard
5.2. Switzerland Biosensors Market: Application Movement Analysis
5.3. Switzerland Biosensors Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Medical
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.2. Cholesterol
5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.3. Blood Glucose
5.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.4. Pregnancy Testing
5.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.5. Drug Discovery
5.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.6. Infectious Disease
5.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Food Toxicity
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Bioreactor
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.7. Agriculture
5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.8. Environment
5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. SWITZERLAND BIOSENSORS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Switzerland Biosensors Market: End Use Dashboard
6.2. Switzerland Biosensors Market: End Use Movement Analysis
6.3. Switzerland Biosensors Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Home Healthcare Diagnostics
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. PoC Testing
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Food industry
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.7. Research Laboratories
6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.8. Security and Bio-defense
6.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Abbott Laboratories
7.3.4.1. Company Overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Biosensors International Group Ltd
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Bayer AG
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Xsensio
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Lucentix SA
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Sensirion AG Switzerland
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Innovative Sensor Technology (IST) AG
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
